OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-04-05-accounts

C ON T EN TS
Management
and Committees
Legal and Administrative
information
Report ofthe Trustees
Pain Relief Foundation
Aims and Policies
Chronic Pain
Research and the Institute
Research Accommodation 10
Management
Structure
& Governance
12
Risk Management
&assessment
13
Trustee Recruitment 13
Advisory Sub-Committees 14
Grant Making
&Policies
15
Public Benefit 16
Powers ofInvestment
& Investment
Policy 17
Reserves 18
Fundraising
Regulator
&our fundraising
promise 19
Donation Policy 20to 21
Statement of Trustee Responsibilities 22
Clinical Section & Education 23 to 26
Research Reports 26 to28
Auditor's
Report
29 to 31
Statement ofFinancial Activities 32
Balance Sheet 33 to34
Cash Flow Statement 35to 36
Notes forming part ofthe Financial Statements 37to 44
Detailed statement ofFinancial Activities 45 to 46

Costs for 50%oft he Chairin Pain Science,
University

ofLiverpool.

ofLiverpool.
Dr Maria Maiaru 'Targeting
ion channels
to combat pathophysiology
of
663,140
Reading chemotherapy-induced peripheral neuropathy (over 3years)
Dr Anne Marshall 'REliabilily ofHRDD as a biomarkerin
Painful
diabeti
Liverpool cnEuropathy
-a validation
study
(REPEL) 525,763
(Over 8months)

5.4.23 5.4.22
Unrestricted Restricted Total Total
Notes funds
f
fundf funds funds
INCOME AND ENDOWMENTS FROM
Donations
and legacies
3 373,501 373,501 184,392
Other trading
activities
42,523 42,523 4,254
Investment
income
95,054 95,054 89,475
Total 511,078 511,078 278,121
EXPENDITURE ON
Raising funds
Other trading
activities
5 14,837 14,837 14,677
Investment
management
costs 7 12017 12,017 12,469
26,854 26,854 27,146
Charitable
activities
8
Research 469,382 300 469,682 413,088
Education 5,759
Total 496,236 300 496,536 445,993
Net gains/(losses)
on investments
$151,442) $151,442) 254,619
NET INCOME/(EXPENDITURE) (136,600) (300) (136,900) 86,747
RECONCILIATION
OF
FUNDS
Total funds brought
forward
3,001,458 25,643 3,027,101 2,940,354
TOTAL FUNDS CARRIED FORWARD 2,864,858 25,343 2,890,201 3,027,101

5.4.23 5.4.22
Unrestricted Restricted Total Total
Notes funds
f
fund
5
funds fundsf
FIXEDASSETS
Tangible assets 14 61,366 901 62,267 73,117
Investments 15 2,695,242 2,695,242 2,949,283
2,756,608 901 2,757,509 3,022,400
CURRENT ASSETS
Stocks 16 662 662 700
Debtors 17 (3,724) (3,724) 9,558
Cash at bank and in hand 179,314 24,442 203,756 45,291
176,252 24,442 200,694 55,549
CREDITORS
Amounts
falling due within one year
18 (68,002) (68,002) (50,848)
NET CURRENT ASSETS 108,250 24,442 132,692 4,701
TOTAL ASSETS LESSCURRENT 2,864,858 25,343 2,890,201 3,027,101
LIABILITIES
NET ASSETS 2,864,858 25,343 2,890,201 3,027,101
FUNDS 20
Unrestricted
funds:
General
fund
141,987 31,380
Designated
unrestricted
2,722,871 2,970,078
2,864,858 3,001,458
Restricted funds:
Restricted
fund
25,343 25,543
TOTAL FUNDS 2,890,201 3,027,101

Notes 5.4.23 5.4.22
f
Cash flows from operating activities
Cash generated
from operations
1 (39,408) (243,957)
Finance costs paid (340) (261)
Tax paid 12,051 ~6,163
Net cash used
in operating
activities (27,595) (250,381)
Cash flows from investing activities
Purchase offixed asset investments (71,543) (222,186)
Sale oftangible
fixed assets
1,186
Sale of5xed asset investments 174,142 332,787
Interest received 2
Dividends
received
95,052 89,473
Net cash provided
by investing
activities 197,553 201,260
Change
in cash and cash
equivalents
in the reporting
period 189,958 (49,121)
Cash and cash equivalents at the
beginning
ofthe reporting
period 2 33,798 82,919
Cash and cash equivalents at the
end ofthe reporting
period
203,755 33,798

5.4.23 5.4.22
Net (expenditure)/income for the reporting period (as per
the Statement ofFinancial Activities) (136,900) 86,747
Adjustments
for:
Depreciation
charges
10,850 13,380
Losses/(gain)
on investments
151,442 (254,619)
Profit on disposal of fixed assets (1,186)
Interest received (2)
Finance costs 340 261
Dividends
received
(95,052) (89,473)
Decrease
in stocks
38 76
Decrease
in debtors
1,231 8,038
Increase/(decrease) in creditors 28,647 ~7,181
Net cash used
in operations
~39,406) (243,957)
2, ANALYSIS OF CASH AND CASH EQUIVALENTS
5.4.23 5.4.22
6 f
Cash in hand 4 4
Notice deposits (less than 3 months) 203,752 45,287
Overdrafts
included
in bank loans and overdrafts falling due within (11,493)
one year
Total cash and cash equivalents 203,756 33,798

ANALYSIS OF C HANGES
IN NET FUN
DS
At 6.4.22 Cash flow At 5.4.23
f 6
Net cash
Cash at bank and in hand 45,291 158,465 203,756
Bank overdraft {11,493) 11,493
33,798 169,958 203,756
Total 33,798 169,958 203,756

costs ofthe chair ofProfess or of Pai n.
2023 2022
investment
income:
Interest received 1,709 2,908
Dividends 93,342 86,564
Realised gains on investments sold (3,267) 100,175
Unrealised
gain on revaluing
investments to market value
Total designated
income
91,784 189,647
Less:
Realised loss on sale ofinvestments
Unrealised
profit/(loss)
on revaluing
investments to market value (148,175) 154,444
(12,017) (12,469)
Expenditure
out ofdesignated
Transfer ofnet expenditure
to
funds
General
Fund ~178SOD ~227 DDO
Net designated
(expenditure)/income
(247,207) 104,622
ACCOUNTING
POLICIES

3. DONATIONS
AND LEGACIES
5.4.23
f
5.4.22
f
Gifts 68,197 89,086
Gift aided donations 5,846 29,047
Tax recovered
on gift aided donations
(4,789) 7,262
Legacies 303,436 58,530
Sundry income 811 467
373,501 184,392
4. OTHER TRADING ACTIVITIES
5.4.23
F
5.4.22
f
Fundraising
events
950
Books leaflets tapes 133 145
Sponsorships 6,217 100
EFICCancer School 31,173
Meeting fees 4,050 4,009
42,523 4,254
5. INVESTMENT INCOME
5.4.23 5.4.22
f
Rents received 2
Listed investments 95,052 89,473
Deposit account interest 2
95,054 89,475
6. OTHER TRADING ACTIVITIES
5.4.23
f
5.4.22
f
Purchases 63 76
Staff costs 14,774 14,601
14,837 14,677
7, INVESTMENT MANAGEMENT COSTS
5.4.23
f
5.4.22
f
Portfolio management 12,017 12,469

CHARITA BLE ACTIVITIES CO STS
Grant
funding of
activities Support
Direct (see note costs (see
Costs 9) note 10) Totals
F 6 8
Research 106,646 291,932 71,104 469,682
GRANTS PAYABLE
5.4.23 5.4.22
6 f
Research 291,932 282,658
10. SUPPORT COSTS
Information Governance
Management Finance technology costs
Totals
F 6
Research 39,671 329 5,251 25,853 71,104

5.4.23 5.4.22
f
Auditors' remuneration 5,000 5,000
Auditors' remuneration for non audit work 3,340 3,340
Depreciation
- owned assets
10,850 13,379
Other operating
leases
6,426 3,975
Surplus on disposal of fixed assets ~1,186)

TANGIBLE FIXEDASSETS
Fixtures
Long Plant and and
leasehold
F
machinery
f
fittings Totals
F
COST
At 8 April 2022 and 5 April 2023 114,302 204,403 324,487 643,192
DEPRECIATION
At 6 April 2022 71,521 176,435 322,119 570,075
Charge for year 3,266 6,992 592 10,850
At 5 April 2023 74,787 183,427 322,711 580,925
NET BOOK VALUE
At 5 April 2023 39,515 20,976 1,776 62,267
At 5 April 2022 42,781 27,968 2,368 73,117

FIXEDA SSET INVESTMENTS
Listed
investments
F
MARKET VALUE
At 6 April 2022 2,949,283
Additions at cost 71,543
Disposals at book cost
Revaluations
(177,409)
$148,175)
At 5 April 2023 2,695,242
NET BOOK VALUE
At 5April 2023 2,695,242
At 5 April 2022 2,949,283
Valuation in 2023
Cost

16. STOCKS
5.4.23
f
5.4.22
f
Finished goods 662 700
17. DEBTORS:AMOUNTS FALLING DUE WITHIN ONE YEAR
5.4.23
f
5.4.22
f
Tax (4,789) 7,262
Prepayments and accrued income 1,065 2,296
(3,724) 9,558
18. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
5.4.23 5.4.22
f
Bank loans and overdrafts (see note 19) 11,493
Social security and other taxes 123
Accruals and deferred income 68,002 39,232
68,002 50,848
19. LOANS
An analysis of the maturity ofloans is given below:
5.4.23 5.4.22
f
Amounts
falling due within
one year on demand:
Bank overdrafts 11,493
20. MOVEMENT IN FUNDS
Net Transfers
movement between At
At 6.4.22 in funds funds 5.4.23
f. f f
Unrestricted funds
General fund
Designated
unrestricted
31,380
2,970,078
(68,193)
~6$,4D7)
178,800
$178,800)
141,987
2,722,871
3,001,458 (136,600) 2,864,858
Restricted funds
Restricted
fund
25,643 (300) 25,343
TOTAL FUNDS 3,027,101 J136,9DD) 2,890,201
Continued ..

Net movem ent
in funds, included
in the above are as fo llows:
Incoming Resources Gains and Movement
resources
f
expended
f
losses
f
in funds
f.
Unrestricted
funds
General fund 416,026 (484,219) (68,193)
Designated unrestricted ~95 052 (12,017) (151,442) (68,407)
511,078 (496,236) (151,442) (136,600)
Restricted funds
Restricted fund (300) (300)
TOTAL FUNDS 511,078 (496,536) (151,442) (136,900)

Net Transfers
movement between At
At 6.4.21
f
in funds
f
funds
f
5.4.22
f
Unrestricted
funds
General
fund
73,854 (269,474) 227,000 31,380
Designated unrestricted 2,865,456 331622 ~227,000) 2,970,078
2,939,310 62,148 3,001,458
Restricted funds
Restricted fund 1,044 24,599 25,643
TOTAL FUNDS 2,940,354 86,747 3,027,101
Comparativ e
net movement
in fu
nds,
included
in the ab
ove are as foll ows:
Incoming Resources Gains and Movement
resources
f
expended
f
losses
f
in funds
f
Unrestricted
funds
General fund 163,649 (433,123) (269,474)
Designated unrestricted 89,472 ~12,469) 254,619 331,622
253,121 (445,592) 254,619 62,148
Restricted funds
Restricted fund 25,000 (401) 24,599
TOTAL FUNDS 278,121 (445,993) 254,619 86,747

Net Transfers
movement between At
At6.4.21 in funds
f
funds
f
5.4.23
f
Unrestricted
funds
General fund 73,854 (337,667) 405,800 141,987
Designated unrestricted 2,865,456 263,215 ~405,800) 2,722,871
2,939,310 (74,452) 2,864,858
Restricted funds
Restricted fund 1,044 24,299 25,343
TOTAL FUNDS 2,940,354 ~50,153) 2,890,201
A current
the above
year 12 months
and pri
are as follows:
or year 12 months
com
bined
net mov
ement
in fund
s,
included
Incoming Resources Gains and Movement
resources
6
expended losses
f
in funds
6
Unrestricted
funds
General
fund
579,675 (917,342) (337,667)
Designated unrestricted 184,524 (24,486) 103,177 263,215
764,199 (941,828) 103,177 (74,452)
Restricted funds
Restricted fund 25,000 (701) 24,299
TOTAL FUNDS 789,199 (942,529) 103,177 (50,153)

5.4.23 5.4.22
5 6
INCOME AND ENDOWMENTS
Donations
and
legacies
Gifts 68,197 89,088
Gift aided donations 5,846 29,047
Tax recovered on gift aided donations (4,789) 7,252
Legacies 303,436 58,530
Sundry
income
811 467
373,501 184,392
Other trading activities
Fundraising
events
950
Books leaflets tapes 133 145
Sponsorships 6,217 100
EFIC Cancer School 31,173
Meeting fees 4,050 4,009
42,523 4,254
Investment
income
Rents received 2
Listed investments 95,052 89,473
Deposit account interest 2
95,054 89,475
Total incoming resources 511,078 278,121
EXPENDITURE
Other trading activities
Purchases 63 76
Wages 14,300 14,100
Social security 306 343
Pensions 168 158
14,837 14,677
Investment
management
costs
Portfolio management 12,017 12,469
Charitable
activities
Wages 54,393 50,675
Social security 1,057 1,543
Pensions 1,684 1,584
Venue &meeting costs 37,473 2,468
Sundry 1,189 278
Depreciation
of
tangible fixed assets 10,850 13,380
Loss on sale of tangible fixed assets (1,186)
Grants to individuals 291,932 282,558
398,578 351,400

5.4.23f 5.4.22f
Supportcosts
Management
Other operating
leases
6,426 3,975
Rates and water 17,505 17,548
Insurance 2,974 2,571
Telephone 1,117 1,047
Postage and stationery 2,936 1,791
Advertising 5,252 7,611
Sundries 1,002 235
Travel 852 501
Computer
software
1,267 1,352
Credit card charges 340 261
39,671 36,892
Finance
Bank charges 329 150
Information
technology
Repairs and renewals 5,251 5,056
Governance costs
Wages 16,600 15,800
Social security 239 370
Pensions 674 634
Auditors'
remuneration
5,000 5,000
Auditors'
remuneration
for non audit work 3,340 3,340
Postage and stationery 205
25,853 25,349
Total resources expended 496,536 445,993
Net income/(expenditure) before gains
and losses 14,542 (167,872)
Realised recognised
Net investment
gains/
gains and losses
(losses)
J3,267) 100,175
Net income/(expenditure) 11,275 ~67,697)

Pain Relief Foundation